liraglutide 3.0 mg

liraglutide · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for liraglutide 3.0 mg, covering 2019-07-30 to 2022-06-23. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity [Phase 2]